-DOCSTART- -X- O
The -X- _ O
study -X- _ O
aimed -X- _ O
to -X- _ O
examine -X- _ O
for -X- _ O
the -X- _ O
first -X- _ O
time -X- _ O
the -X- _ O
spectra -X- _ O
of -X- _ O
viral -X- _ O
and -X- _ O
bacterial -X- _ O
pathogens -X- _ O
along -X- _ O
with -X- _ O
the -X- _ O
antibiotic -X- _ O
susceptibility -X- _ O
of -X- _ O
the -X- _ O
isolated -X- _ O
bacteria -X- _ O
in -X- _ O
under-5 -X- _ B-Patient
children -X- _ I-Patient
with -X- _ I-Patient
acute -X- _ I-Patient
respiratory -X- _ I-Patient
infections -X- _ I-Patient
( -X- _ I-Patient
ARIs -X- _ I-Patient
) -X- _ I-Patient
in -X- _ O
hospital -X- _ O
settings -X- _ O
of -X- _ O
Dhaka -X- _ O
, -X- _ O
Bangladesh. -X- _ O
Nasal -X- _ O
swabs -X- _ O
were -X- _ O
collected -X- _ O
from -X- _ O
200 -X- _ B-Patient
under-five -X- _ I-Patient
children -X- _ I-Patient
hospitalized -X- _ I-Patient
with -X- _ I-Patient
clinical -X- _ I-Patient
signs -X- _ I-Patient
of -X- _ I-Patient
ARIs. -X- _ I-Patient
Nasal -X- _ O
swabs -X- _ O
from -X- _ O
30 -X- _ B-Comparison
asymptomatic -X- _ I-Comparison
children -X- _ I-Comparison
were -X- _ O
also -X- _ O
collected. -X- _ O
Screening -X- _ O
of -X- _ O
viral -X- _ O
pathogens -X- _ O
targeted -X- _ O
ten -X- _ O
respiratory -X- _ O
viruses -X- _ O
using -X- _ O
RT-qPCR. -X- _ O
Bacterial -X- _ O
pathogens -X- _ O
were -X- _ O
identified -X- _ O
by -X- _ O
bacteriological -X- _ O
culture -X- _ O
methods -X- _ O
and -X- _ O
antimicrobial -X- _ O
susceptibility -X- _ O
of -X- _ O
the -X- _ O
isolates -X- _ O
was -X- _ O
determined -X- _ O
following -X- _ O
CLSI -X- _ O
guidelines. -X- _ O
About -X- _ B-Outcome
82.5 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
165 -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
specimens -X- _ I-Outcome
were -X- _ I-Outcome
positive -X- _ I-Outcome
for -X- _ I-Outcome
pathogens. -X- _ I-Outcome
Of -X- _ I-Outcome
165 -X- _ I-Outcome
infected -X- _ I-Outcome
cases -X- _ I-Outcome
, -X- _ I-Outcome
3 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
6 -X- _ I-Outcome
) -X- _ I-Outcome
had -X- _ I-Outcome
only -X- _ I-Outcome
single -X- _ I-Outcome
bacterial -X- _ I-Outcome
pathogens -X- _ I-Outcome
, -X- _ I-Outcome
whereas -X- _ I-Outcome
43.5 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
87 -X- _ I-Outcome
) -X- _ I-Outcome
cases -X- _ I-Outcome
had -X- _ I-Outcome
only -X- _ I-Outcome
single -X- _ I-Outcome
viral -X- _ I-Outcome
pathogens. -X- _ I-Outcome
The -X- _ I-Outcome
remaining -X- _ I-Outcome
36 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
72 -X- _ I-Outcome
) -X- _ I-Outcome
cases -X- _ I-Outcome
had -X- _ I-Outcome
coinfections. -X- _ I-Outcome
In -X- _ I-Outcome
symptomatic -X- _ I-Outcome
cases -X- _ I-Outcome
, -X- _ I-Outcome
human -X- _ I-Outcome
rhinovirus -X- _ I-Outcome
was -X- _ I-Outcome
detected -X- _ I-Outcome
as -X- _ I-Outcome
the -X- _ I-Outcome
predominant -X- _ I-Outcome
virus -X- _ I-Outcome
( -X- _ I-Outcome
31.5 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
followed -X- _ I-Outcome
by -X- _ I-Outcome
RSV -X- _ I-Outcome
( -X- _ I-Outcome
31 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
HMPV -X- _ I-Outcome
( -X- _ I-Outcome
13 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
HBoV -X- _ I-Outcome
( -X- _ I-Outcome
11 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
HPIV-3 -X- _ I-Outcome
( -X- _ I-Outcome
10.5 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
adenovirus -X- _ I-Outcome
( -X- _ I-Outcome
7 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Streptococcus -X- _ I-Outcome
pneumoniae -X- _ I-Outcome
was -X- _ I-Outcome
the -X- _ I-Outcome
most -X- _ I-Outcome
frequently -X- _ I-Outcome
isolated -X- _ I-Outcome
bacterial -X- _ I-Outcome
pathogen -X- _ I-Outcome
( -X- _ I-Outcome
9 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
whereas -X- _ I-Outcome
Klebsiella -X- _ I-Outcome
pneumaniae -X- _ I-Outcome
, -X- _ I-Outcome
Streptococcus -X- _ I-Outcome
spp. -X- _ I-Outcome
, -X- _ I-Outcome
Enterobacter -X- _ I-Outcome
agglomerans -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
Haemophilus -X- _ I-Outcome
influenzae -X- _ I-Outcome
were -X- _ I-Outcome
5.5 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
5 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
2 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
1.5 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
respectively. -X- _ I-Outcome
Of -X- _ I-Outcome
15 -X- _ I-Outcome
multidrug-resistant -X- _ I-Outcome
bacteria -X- _ I-Outcome
, -X- _ I-Outcome
a -X- _ I-Outcome
Klebsiella -X- _ I-Outcome
pneumoniae -X- _ I-Outcome
isolate -X- _ I-Outcome
and -X- _ I-Outcome
an -X- _ I-Outcome
Enterobacter -X- _ I-Outcome
agglomerans -X- _ I-Outcome
isolate -X- _ I-Outcome
exhibited -X- _ I-Outcome
resistance -X- _ I-Outcome
against -X- _ I-Outcome
more -X- _ I-Outcome
than -X- _ I-Outcome
10 -X- _ I-Outcome
different -X- _ I-Outcome
antibiotics. -X- _ I-Outcome
Both -X- _ I-Outcome
ARI -X- _ I-Outcome
incidence -X- _ I-Outcome
and -X- _ I-Outcome
predominant -X- _ I-Outcome
pathogen -X- _ I-Outcome
detection -X- _ I-Outcome
rates -X- _ I-Outcome
were -X- _ I-Outcome
higher -X- _ I-Outcome
during -X- _ I-Outcome
post-monsoon -X- _ I-Outcome
and -X- _ I-Outcome
winter -X- _ I-Outcome
, -X- _ I-Outcome
peaking -X- _ I-Outcome
in -X- _ I-Outcome
September. -X- _ I-Outcome
Pathogen -X- _ I-Outcome
detection -X- _ I-Outcome
rates -X- _ I-Outcome
and -X- _ I-Outcome
coinfection -X- _ I-Outcome
incidence -X- _ I-Outcome
in -X- _ I-Outcome
less -X- _ I-Outcome
than -X- _ I-Outcome
1-year -X- _ I-Outcome
group -X- _ I-Outcome
were -X- _ I-Outcome
significantly -X- _ I-Outcome
higher -X- _ I-Outcome
( -X- _ I-Outcome
P -X- _ I-Outcome
= -X- _ I-Outcome
0.0034 -X- _ I-Outcome
and -X- _ I-Outcome
0.049 -X- _ I-Outcome
, -X- _ I-Outcome
respectively -X- _ I-Outcome
) -X- _ I-Outcome
than -X- _ I-Outcome
in -X- _ I-Outcome
1â€“5 -X- _ I-Outcome
years -X- _ I-Outcome
age -X- _ I-Outcome
group. -X- _ I-Outcome
Pathogen -X- _ I-Outcome
detection -X- _ I-Outcome
rate -X- _ I-Outcome
( -X- _ I-Outcome
43 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
in -X- _ I-Outcome
asymptomatic -X- _ I-Outcome
cases -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
lower -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
symptomatic -X- _ I-Outcome
group -X- _ I-Outcome
( -X- _ I-Outcome
P -X- _ I-Outcome
< -X- _ I-Outcome
0.0001 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Human -X- _ I-Outcome
rhinovirus -X- _ I-Outcome
, -X- _ I-Outcome
HPIV-3 -X- _ I-Outcome
, -X- _ I-Outcome
adenovirus -X- _ I-Outcome
, -X- _ I-Outcome
Streptococcus -X- _ I-Outcome
pneumonia -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
Klebsiella -X- _ I-Outcome
pneumaniae -X- _ I-Outcome
had -X- _ I-Outcome
significant -X- _ I-Outcome
involvement -X- _ I-Outcome
in -X- _ I-Outcome
coinfections -X- _ I-Outcome
with -X- _ I-Outcome
P -X- _ I-Outcome
values -X- _ I-Outcome
of -X- _ I-Outcome
0.0001 -X- _ I-Outcome
, -X- _ I-Outcome
0.009 -X- _ I-Outcome
and -X- _ I-Outcome
0.0001 -X- _ I-Outcome
, -X- _ I-Outcome
0.0001 -X- _ I-Outcome
and -X- _ I-Outcome
0.001 -X- _ I-Outcome
respectively. -X- _ I-Outcome
Further -X- _ O
investigations -X- _ O
are -X- _ O
required -X- _ O
to -X- _ O
better -X- _ O
understand -X- _ O
the -X- _ O
clinical -X- _ O
roles -X- _ O
of -X- _ O
the -X- _ O
isolated -X- _ O
pathogens -X- _ O
and -X- _ O
their -X- _ O
seasonality -X- _ O
. -X- _ O

